Slate Path Capital LP Has Lowered Its Alnylam Pharmaceuticals (ALNY) Position; SHISEIDO COMPANY LTD ORD (SSDOF) Sellers Decreased By 25.65% Their Shorts

February 18, 2018 - By Pete Kolinski

Slate Path Capital Lp decreased Alnylam Pharmaceuticals Inc (ALNY) stake by 50.57% reported in 2017Q3 SEC filing. Slate Path Capital Lp sold 574,000 shares as Alnylam Pharmaceuticals Inc (ALNY)’s stock rose 48.45%. The Slate Path Capital Lp holds 561,000 shares with $65.91 million value, down from 1.14 million last quarter. Alnylam Pharmaceuticals Inc now has $12.25B valuation. The stock increased 0.94% or $1.14 during the last trading session, reaching $122.88. About 653,512 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has risen 33.54% since February 18, 2017 and is uptrending. It has outperformed by 16.84% the S&P500.

SHISEIDO COMPANY LTD ORD (OTCMKTS:SSDOF) had a decrease of 25.65% in short interest. SSDOF’s SI was 403,700 shares in February as released by FINRA. Its down 25.65% from 543,000 shares previously. With 700 avg volume, 577 days are for SHISEIDO COMPANY LTD ORD (OTCMKTS:SSDOF)’s short sellers to cover SSDOF’s short positions. It closed at $54.9 lastly. It is down 0.00% since February 18, 2017 and is . It has underperformed by 16.70% the S&P500.

Shiseido Company, Limited produces and sells cosmetics, cosmetics accessories, and toiletries in Japan and internationally. The company has market cap of $22.90 billion. It also produces and sells health and beauty foods, and over-the-counter drugs; and beauty salon products. It has a 103 P/E ratio. In addition, the firm operates beauty salons, as well as restaurants.

Investors sentiment decreased to 0.92 in 2017 Q3. Its down 0.60, from 1.52 in 2017Q2. It dived, as 30 investors sold ALNY shares while 73 reduced holdings. 40 funds opened positions while 55 raised stakes. 86.02 million shares or 0.72% more from 85.40 million shares in 2017Q2 were reported. Dodge And Cox stated it has 9.14M shares or 0.86% of all its holdings. Vanguard Grp Inc has 0.04% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). M&T Retail Bank reported 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Bb Biotech Ag owns 3.61% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 1.11M shares. Moreover, Swiss Comml Bank has 0.02% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Glenmede Trust Com Na invested 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Pnc Group Inc accumulated 8,799 shares. Arrowstreet Partnership accumulated 51,485 shares. 63,312 are held by Parametric Assocs Ltd Llc. Panagora Asset Management Inc reported 2,725 shares. Broadfin Capital Limited Liability reported 74,208 shares. Tortoise Mngmt Limited Liability Com has 198 shares. Evercore Wealth Management Llc has invested 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). 35,000 were reported by Ghost Tree Capital Ltd Liability Corp. Moreover, Utd Svcs Automobile Association has 0.01% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 34,700 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>